Correlation Between Armata Pharmaceuticals and Scholar Rock
Can any of the company-specific risk be diversified away by investing in both Armata Pharmaceuticals and Scholar Rock at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Armata Pharmaceuticals and Scholar Rock into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Armata Pharmaceuticals and Scholar Rock Holding, you can compare the effects of market volatilities on Armata Pharmaceuticals and Scholar Rock and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Armata Pharmaceuticals with a short position of Scholar Rock. Check out your portfolio center. Please also check ongoing floating volatility patterns of Armata Pharmaceuticals and Scholar Rock.
Diversification Opportunities for Armata Pharmaceuticals and Scholar Rock
0.02 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Armata and Scholar is 0.02. Overlapping area represents the amount of risk that can be diversified away by holding Armata Pharmaceuticals and Scholar Rock Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Scholar Rock Holding and Armata Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Armata Pharmaceuticals are associated (or correlated) with Scholar Rock. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Scholar Rock Holding has no effect on the direction of Armata Pharmaceuticals i.e., Armata Pharmaceuticals and Scholar Rock go up and down completely randomly.
Pair Corralation between Armata Pharmaceuticals and Scholar Rock
Given the investment horizon of 90 days Armata Pharmaceuticals is expected to under-perform the Scholar Rock. But the stock apears to be less risky and, when comparing its historical volatility, Armata Pharmaceuticals is 4.5 times less risky than Scholar Rock. The stock trades about 0.0 of its potential returns per unit of risk. The Scholar Rock Holding is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 1,880 in Scholar Rock Holding on August 25, 2024 and sell it today you would earn a total of 1,112 from holding Scholar Rock Holding or generate 59.15% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Armata Pharmaceuticals vs. Scholar Rock Holding
Performance |
| Timeline |
| Armata Pharmaceuticals |
| Scholar Rock Holding |
Armata Pharmaceuticals and Scholar Rock Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Armata Pharmaceuticals and Scholar Rock
The main advantage of trading using opposite Armata Pharmaceuticals and Scholar Rock positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Armata Pharmaceuticals position performs unexpectedly, Scholar Rock can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Scholar Rock will offset losses from the drop in Scholar Rock's long position.| Armata Pharmaceuticals vs. Eliem Therapeutics | Armata Pharmaceuticals vs. HCW Biologics | Armata Pharmaceuticals vs. Scpharmaceuticals | Armata Pharmaceuticals vs. Milestone Pharmaceuticals |
| Scholar Rock vs. Revolution Medicines | Scholar Rock vs. Black Diamond Therapeutics | Scholar Rock vs. Passage Bio | Scholar Rock vs. Monte Rosa Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |